Skip Nav Destination

Pfizer

Free access sponsored by Pfizer (Pharmacia)

The Regulation of Pubertal Growth

Dennis M. Styne

https://doi.org/10.1159/000071222

Preface

Michael B. Ranke; Ulla Feldt-Rasmussen

https://doi.org/10.1159/000071218

The Transition from Adolescence to Adult Life: Physiology of the ‘Transition’ Phase and Its Evolutionary Basis

Ron G. Rosenfeld; Barbara C. Nicodemus

https://doi.org/10.1159/000071230

Pubertal Changes in Biochemical Markers of Growth

Giovanni Federico; Giampiero I. Baroncelli; Teresa Vanacore; Lisa Fiore; Giuseppe Saggese

https://doi.org/10.1159/000071225

Prediction Model of Total Pubertal Growth in Idiopathic Growth Hormone Deficiency: Analysis of Data from KIGS

Michael B. Ranke; David D. Martin; Anders Lindberg; o on behalf of the KIGS International Board

https://doi.org/10.1159/000071227

Early-Onset Idiopathic Growth Hormone Deficiency within KIGS

Michael B. Ranke; Anders Lindberg; o on behalf of the KIGS International Board

https://doi.org/10.1159/000071221

Author Index

https://doi.org/10.1159/000073321

Subject Index

https://doi.org/10.1159/000073322

Effects of Ageing on Insulin Secretion and Action

Niels Møller; Lars Gormsen; Jens Fuglsang; Jakob Gjedsted

https://doi.org/10.1159/000071233

Title Page / Table of Contents

https://doi.org/10.1159/000073320

The Effects of Growth Hormone and Sex Steroid on Lean Body Mass, Fat Mass, Muscle Strength, Cardiovascular Endurance and Adverse Events in Healthy Elderly Women and Men

S. Mitchell Harman; Marc R. Blackman

https://doi.org/10.1159/000071236

The Effects of Manipulation of Puberty on Growth

Peter A. Lee

https://doi.org/10.1159/000071228

The KIGS Experience with the Addition of Gonadotropin-Releasing Hormone Agonists to Growth Hormone (GH) Treatment of Children with Idiopathic GH Deficiency

Edward O. Reiter; Anders Lindberg; Michael B. Ranke; David A. Price; Kerstin Albertsson-Wikland; Christopher T. Cowell; Bert Bakker

https://doi.org/10.1159/000071229

Growth Hormone Deficiency: Strategies and Indications to Continue Growth Hormone Therapy in Transition from Adolescence to Adult Life

Gary M. Leong; Gudmundur Johannsson

https://doi.org/10.1159/000071231

Growth Hormone Deficiency (GHD) from Birth to 2 Years of Age: Diagnostic Specifics of GHD during the Early Phase of Life

Amanda L. Ogilvy-Stuart

https://doi.org/10.1159/000071219

A Tripeptidyl Ensemble Perspective of Interactive Control of Growth Hormone Secretion

Johannes D. Veldhuis

https://doi.org/10.1159/000071232

Growth Hormone (GH) Status and Body Composition in Normal Ageing and in Elderly Adults with GH Deficiency

Andrew A. Toogood

https://doi.org/10.1159/000071234

Aspects of Growth Hormone (GH) Replacement in Elderly Patients with GH Deficiency: Data from KIMS

John P. Monson; Peter Jönsson

https://doi.org/10.1159/000071235

Pubertal Growth Assessment

Johan Karlberg; Chi-wai Kwan; Lars Gelander; Kerstin Albertsson-Wikland

https://doi.org/10.1159/000071223

Treatment of Growth Hormone Deficiency in Very Young Children

Jean-Claude Carel; Frédéric Huet; Jean-Louis Chaussain

https://doi.org/10.1159/000071220

1 2

Pfizer

INFORMATION

ABOUT US

SERVICES FOR

Karger International

Pfizer

This Feature Is Available To Subscribers Only